We are live on ! Find out more
PP

PDT Partners Portfolio holdings

AUM $1.69B
1-Year Est. Return 74.01%
This Fund
S&P 500
This Quarter Est. Return
+9.85%
1 Year Est. Return
+74.01%
3 Year Est. Return
+179.69%
5 Year Est. Return
+210.81%
10 Year Est. Return
+1,321.68%
AUM
$1.13B
AUM Growth
+$72.2M
Cap. Flow
+$9.62M
Cap. Flow %
0.85%
Top 10 Hldgs %
7.17%
Holding
858
New
204
Increased
192
Reduced
260
Closed
148

Top Buys

Rank Stock Value
1
WMB icon
Williams Companies
WMB
+$4.82M
2
VFC icon
VF Corp
VFC
+$4.71M
3
INSP icon
Inspire Medical Systems
INSP
+$4.06M
4
GLW icon
Corning
GLW
+$3.96M
5
PCRX icon
Pacira BioSciences
PCRX
+$3.94M

Top Sells

Rank Stock Value
1
SPOT icon
Spotify
SPOT
+$7.22M
2
UBER icon
Uber
UBER
+$5.67M
3
TEAM icon
Atlassian
TEAM
+$5.66M
4
HOOD icon
Robinhood
HOOD
+$5.36M
5
NTLA icon
Intellia Therapeutics
NTLA
+$4.9M

Sector Composition

Rank Sector Weight
1 Healthcare 20.98%
2 Technology 20.39%
3 Industrials 14.03%
4 Consumer Discretionary 11.34%
5 Financials 10.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GILT icon
676
Gilat Satellite Networks
GILT
$812M
$145K 0.01%
27,453
+9,287
+51% +$42.7K
TK icon
677
Teekay
TK
$981M
$141K 0.01%
+15,371
New +$128K
ATXS
678
DELISTED
Astria Therapeutics
ATXS
$140K 0.01%
+12,749
New +$142K
IHS icon
679
IHS Holding
IHS
$2.78B
$140K 0.01%
46,705
EDIT icon
680
Editas Medicine
EDIT
$402M
$135K 0.01%
39,546
-206,991
-84% -$901K
VMEO
681
DELISTED
Vimeo
VMEO
$133K 0.01%
26,243
-102,088
-80% -$463K
BRDG
682
DELISTED
Bridge Investment Group
BRDG
$132K 0.01%
13,361
-4,414
-25% -$36K
CRD.A icon
683
Crawford & Co Class A
CRD.A
$551M
$132K 0.01%
11,999
AVD icon
684
American Vanguard Corp
AVD
$74.1M
$130K 0.01%
+24,609
New +$174K
VYGR icon
685
Voyager Therapeutics
VYGR
$184M
$130K 0.01%
22,163
-53,542
-71% -$389K
BLFY
686
DELISTED
Blue Foundry Bancorp
BLFY
$129K 0.01%
+12,579
New +$131K
OABI icon
687
OmniAb
OABI
$286M
$123K 0.01%
+29,011
New +$125K
AMPY icon
688
Amplify Energy
AMPY
$152M
$122K 0.01%
18,739
-18
-0.1% -$125
NBIS
689
Nebius Group N.V.
NBIS
$43.1B
$122K 0.01%
10,169
COTY icon
690
Coty
COTY
$2.45B
$118K 0.01%
12,541
-231,231
-95% -$2.2M
ORN icon
691
Orion Group Holdings
ORN
$485M
$114K 0.01%
19,701
-23,790
-55% -$183K
IRWD icon
692
Ironwood Pharmaceuticals
IRWD
$626M
$112K 0.01%
+27,300
New +$147K
EGRX
693
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$112K 0.01%
30,011
KLXE icon
694
KLX Energy Services
KLXE
$41.5M
$108K 0.01%
19,699
+8,901
+82% +$53.9K
AMWL icon
695
American Well
AMWL
$185M
$107K 0.01%
+11,298
New +$95.7K
MUX icon
696
McEwen Inc
MUX
$1.03B
$101K 0.01%
+10,877
New +$100K
NVRO
697
DELISTED
NEVRO CORP.
NVRO
$98.7K 0.01%
+17,664
New +$124K
RNW icon
698
ReNew
RNW
$2.22B
$94.8K 0.01%
15,074
-59,836
-80% -$355K
FTK icon
699
Flotek Industries
FTK
$856M
$85.9K 0.01%
+17,246
New +$78.2K
VMD icon
700
Viemed Healthcare
VMD
$457M
$77.7K 0.01%
+10,599
New +$75.7K

Similar funds

PDT Partners's Q3 2024 Portfolio in Review

As of Q3 2024, PDT Partners held 858 positions worth $1.13B, up 6.8% from $1.06B the previous quarter. Its ten largest holdings account for 7.2% of the portfolio.

PDT Partners's Q3 2024 filing shows 204 new, 192 increased, 260 reduced and 148 closed positions. Its largest new stake was Williams Companies: 109,577 shares worth $5M. The largest sale was Spotify, an estimated $7.22M.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Technology and Industrials.

  • PDT Partners's largest Q3 2024 buy was Williams Companies: 109,577 shares worth $5M.
  • PDT Partners added most to e.l.f. Beauty in Q3 2024, an estimated $3.84M increase.
  • PDT Partners's biggest Q3 2024 reduction was Spotify, cutting an estimated $7.22M.
  • PDT Partners fully exited Atlassian in Q3 2024, selling an estimated $5.66M.
  • PDT Partners's ten largest holdings make up 7.2% of its $1.13B portfolio in Q3 2024.
  • PDT Partners opened 204 new positions and closed 148 in Q3 2024.
  • PDT Partners's portfolio value rose 6.8% quarter-over-quarter to $1.13B.

Based on PDT Partners's 13F filing for Q3 2024, filed 14 Nov 2024.